Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) is the most common primary malignancy of the liver, typically arising in the setting of chronic liver inflammation and cirrhosis. It is a highly aggressive tumor characterized by rapid progression and poor prognosis if not detected early.

HCC is primarily driven by chronic inflammation. Major causes include chronic Hepatitis B (HBV) and Hepatitis C (HCV) infections, chronic alcohol consumption, non-alcoholic fatty liver disease (NAFLD/NASH), and exposure to aflatoxins. Genetic predisposition and metabolic disorders like hemochromatosis also play significant roles.

HCC develops through a multi-step process involving chronic liver injury, regeneration, and fibrosis. Persistent inflammation leads to genetic mutations in hepatocytes, leading to dysplasia and eventually malignant transformation. Neovascularization (angiogenesis) is a hallmark of HCC, often feeding the tumor via the hepatic artery.

HCC is the sixth most common cancer globally and the third leading cause of cancer-related death. It is more prevalent in males (2:1 to 4:1 ratio) and typically affects individuals aged 50–7

1. High-incidence regions include East Asia and Sub-Saharan Africa.

• Chronic HBV or HCV infection
• Alcoholic cirrhosis
• NASH/NAFLD
• Aflatoxin exposure
• Hemochromatosis
• Alpha-1 antitrypsin deficiency
• Type 2 Diabetes Mellitus

A. Early Symptoms: Asymptomatic in early stages.
B. Common Symptoms: Abdominal pain, fatigue, unintentional weight loss, loss of appetite.
C. Advanced Symptoms: Jaundice, ascites, hepatomegaly, pruritus, lower extremity edema.
D. Emergency Symptoms: Acute abdominal pain (rupture), hematemesis (variceal bleeding), hepatic encephalopathy.

Inspection may reveal jaundice, spider angiomata, and caput medusae. Palpation often confirms an enlarged, firm, or nodular liver. Auscultation might reveal a hepatic bruit (vascular flow through the tumor).

A. Clinical Assessment: History of liver disease/risk factors.
B. Laboratory Testing: AFP, liver function tests.
C. Imaging Studies: Multiphase CT or MRI.
D. Functional Tests: Child-Pugh Score to assess hepatic reserve.
E. Biopsy Findings: Histological identification of malignant hepatocytes.
F. Genetic Testing: Rare, but sometimes utilized for targeted therapy selection.
G. Differential Diagnosis: Cholangiocarcinoma, hepatic adenoma, liver metastases.

Alpha-Fetoprotein (AFP)
Type: Blood Test
Purpose: Tumor marker screening
Expected Findings: Elevated levels (>200 ng/mL)
Interpretation: Highly suggestive of HCC in high-risk patients.

Contrast-enhanced CT/MRI: Demonstrates "wash-in" (arterial phase) and "wash-out" (venous phase) patterns, which are pathognomonic for HCC.

Cholangiocarcinoma (usually shows delayed enhancement), focal nodular hyperplasia (central scar), and hemangioma (peripheral nodular enhancement).

Portal hypertension, variceal hemorrhage, hepatic failure, metastatic spread (lungs, bones).

A. Lifestyle Modifications: Abstinence from alcohol, weight management.
B. Preventive Measures: HBV vaccination, antiviral therapy for HCV/HBV.
C. Medical Treatment: - Tyrosine Kinase Inhibitors: Sorafenib, Lenvatinib.

• Immunotherapy: Atezolizumab + Bevacizumab.

Prognosis varies by stage; early detection allows for curative resection or transplantation. Advanced disease with vascular invasion generally results in a poor 5-year survival rate.

Screening high-risk patients every 6 months with ultrasound and AFP. Primary prevention via vaccination.

The following homeopathic remedies have been historically indicated for symptoms associated with Hepatocellular Carcinoma. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Hepatocellular Carcinoma.